164 related articles for article (PubMed ID: 32535035)
1. Crk1/2 and CrkL play critical roles in maintaining podocyte morphology and function.
Du J; Meng L; Pang L; Jin B; Duan N; Huang C; Huang H; Li H
Exp Cell Res; 2020 Sep; 394(1):112135. PubMed ID: 32535035
[TBL] [Abstract][Full Text] [Related]
2. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease.
George B; Verma R; Soofi AA; Garg P; Zhang J; Park TJ; Giardino L; Ryzhova L; Johnstone DB; Wong H; Nihalani D; Salant DJ; Hanks SK; Curran T; Rastaldi MP; Holzman LB
J Clin Invest; 2012 Feb; 122(2):674-92. PubMed ID: 22251701
[TBL] [Abstract][Full Text] [Related]
3. Crk1/2 and CrkL form a hetero-oligomer and functionally complement each other during podocyte morphogenesis.
George B; Fan Q; Dlugos CP; Soofi AA; Zhang J; Verma R; Park TJ; Wong H; Curran T; Nihalani D; Holzman LB
Kidney Int; 2014 Jun; 85(6):1382-1394. PubMed ID: 24499776
[TBL] [Abstract][Full Text] [Related]
4. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
5. Essential roles of Crk and CrkL in fibroblast structure and motility.
Park TJ; Curran T
Oncogene; 2014 Oct; 33(43):5121-32. PubMed ID: 24166500
[TBL] [Abstract][Full Text] [Related]
6. The Role of Palladin in Podocytes.
Artelt N; Ludwig TA; Rogge H; Kavvadas P; Siegerist F; Blumenthal A; van den Brandt J; Otey CA; Bang ML; Amann K; Chadjichristos CE; Chatziantoniou C; Endlich K; Endlich N
J Am Soc Nephrol; 2018 Jun; 29(6):1662-1678. PubMed ID: 29720549
[No Abstract] [Full Text] [Related]
7. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
9. Pdlim2 is a novel actin-regulating protein of podocyte foot processes.
Sistani L; Dunér F; Udumala S; Hultenby K; Uhlen M; Betsholtz C; Tryggvason K; Wernerson A; Patrakka J
Kidney Int; 2011 Nov; 80(10):1045-54. PubMed ID: 21814175
[TBL] [Abstract][Full Text] [Related]
10. Plekhh2, a novel podocyte protein downregulated in human focal segmental glomerulosclerosis, is involved in matrix adhesion and actin dynamics.
Perisic L; Lal M; Hulkko J; Hultenby K; Önfelt B; Sun Y; Dunér F; Patrakka J; Betsholtz C; Uhlen M; Brismar H; Tryggvason K; Wernerson A; Pikkarainen T
Kidney Int; 2012 Nov; 82(10):1071-83. PubMed ID: 22832517
[TBL] [Abstract][Full Text] [Related]
11. Mechanical challenges and cytoskeletal impairments in focal segmental glomerulosclerosis.
Feng D; DuMontier C; Pollak MR
Am J Physiol Renal Physiol; 2018 May; 314(5):F921-F925. PubMed ID: 29363327
[TBL] [Abstract][Full Text] [Related]
12. Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.
Potla U; Ni J; Vadaparampil J; Yang G; Leventhal JS; Campbell KN; Chuang PY; Morozov A; He JC; D'Agati VD; Klotman PE; Kaufman L
J Clin Invest; 2014 Apr; 124(4):1757-69. PubMed ID: 24642466
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.
Park T; Large N; Curran T
J Biol Chem; 2021; 296():100390. PubMed ID: 33561443
[TBL] [Abstract][Full Text] [Related]
14. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS.
Gbadegesin RA; Hall G; Adeyemo A; Hanke N; Tossidou I; Burchette J; Wu G; Homstad A; Sparks MA; Gomez J; Jiang R; Alonso A; Lavin P; Conlon P; Korstanje R; Stander MC; Shamsan G; Barua M; Spurney R; Singhal PC; Kopp JB; Haller H; Howell D; Pollak MR; Shaw AS; Schiffer M; Winn MP
J Am Soc Nephrol; 2014 Sep; 25(9):1991-2002. PubMed ID: 24676636
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).
Park T; Koptyra M; Curran T
J Biol Chem; 2016 Dec; 291(51):26273-26290. PubMed ID: 27807028
[TBL] [Abstract][Full Text] [Related]
17. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
[TBL] [Abstract][Full Text] [Related]
18. Planar cell polarity pathway regulates actin rearrangement, cell shape, motility, and nephrin distribution in podocytes.
Babayeva S; Zilber Y; Torban E
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F549-60. PubMed ID: 20534871
[TBL] [Abstract][Full Text] [Related]
19. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
Sever S; Schiffer M
Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
[TBL] [Abstract][Full Text] [Related]
20. The role of filamins in mechanically stressed podocytes.
Greiten JK; Kliewe F; Schnarre A; Artelt N; Schröder S; Rogge H; Amann K; Daniel C; Lindenmeyer MT; Cohen CD; Endlich K; Endlich N
FASEB J; 2021 May; 35(5):e21560. PubMed ID: 33860543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]